Factor H (fllH globulin), 1 an important control protein of the alternative pathway of complement (C) activation, is recognized as having three characteristic functions: (a) acceleration of the decay dissociation of the C3 convertase (C3b,Bb) by binding to C3b and displacing activated factor B (Bb) (1); (b) function as an essential cofactor for the cleavage inactivation of fluid-phase C3b by factor I (C3b-inactivator) (2); and (c) potentiation of the factor I cleavage of bound C3b (1). Factor H also binds to B lymphocyte membrane receptors that are specific for H and triggers the B cells to release endogenous factor I (3). In addition, Hammann and co-workers (4) have recently reported that purified H triggers lymphocyte blastogenesis.
Materials and Methods
Lymphoid Cells. The B lymphoblastoid cell lines known as Raji and BF, and the HSB T lymphoblastoid line were maintained in RPM1 1640 media supplemented with 10% heatinactivated fetal calf serum and antibiotics.
C Components and Sheep Erythrocyte-C3 Complexes (EC3). Human C3, factor B (B), factor H (H),
and factor I(I) were purified from fresh plasma, as previously described (3) . Factor D (D) and nephritic factor (NF) were purified as described by LeSavre et al. (6) and Schreiber et al. (7) . EC3b, containing 1.5-2.5 × 104 molecules of C3b per cell, were prepared by addition of C3 to sheep E, containing the NF-stabilized C3-convertase (8) , and the amount of resulting bound C3b was quantitated by measuring the uptake of [a2~I]monoclonal-anti-C3 (Bethesda Research Laboratories, Gaithersburg, MD) onto a small sample of the EC3b. A portion of the EC3b was converted to EC3bi and EC3d (3) .
Production of Anti-Hand aaH. A goat was immunized intramuscularly with weekly injections of 50 /xg of H emulsified in Freund's complete adjuvant, and the plasma was collected by plasmaphoresis (immunization and plasmaphoresis performed by Dr. Brian F. Tack, Harvard Medical School, Boston, MA). The goat immune plasma was found to be specific for H by Ouchterlony and immunoelectrophoretic analysis with human plasma and various purified C proteins. The IgG fraction of the plasma was isolated by column chromatography on DEAESephaeel (Pharmacia Fine Chemicals, Div. of Pharmaeia Inc., Piscataway, N J) in 0.01 M phosphate buffer, pH 8.0, and then the F(ab')2 fragment was prepared by trypsin digestion (9) and column chromatography on Sephadex G-150 (Pharmaeia Fine Chemicals). The various different H-specific idiotypes of the F(ab')2 anti-H were then purified by absorption and 4 M guanidine elution from agarose containing 10 mg of bound H per ml of gel (10). Two rabbits were immunized weekly at two intramuscular sites with 100/~g of the purified goat F(ab')2 anti-human H emulsified in Freund's complete adjuvant over a period of 3 mo. Nonimmune sera was obtained before immunization, and then immune sera were collected weekly after 6 wk of immunization. After isolation from the rabbit sera of both the nonimmune IgG and the IgG aaH on DEAE-Sephaeel in 0.0175 M phosphate buffer, pH 7.0, antibodies in the aaH directed to common goat IgG determinants were removed by absorption with agarose conjugated (10) to the nonimmune goat IgG obtained by absorption of the goat IgG anti-H with Hagarose. A portion of the absorbed aaH was either labeled with 125I using chloramine T (11), resulting in a specific activity of 6.2 × 104 cpm//~g or, alternatively, was purified by absorption and 4 M guanidine elution from either goat anti-H-agarose or C3-agarose (10 mg IgG anti-H or C3 per ml of gel) and then labeled with 125I (11) to a specific activity of 4-6 × 104 cpm//~g.
Preparation of Antibodies Specific for CR1, CR2, C3b
, and C3c. Antibodies to CRa, CR2, and C3c were prepared in rabbits by immunization with the purified protein antigens (12) (13) (14) . AntiC3b (kindly provided by Dr. Brian F. Tack, Harvard Medical School) was prepared by immunization of sheep with C3b that was generated by elastase digestion of C3 and column chromatography on Sephadex G-200 (Pharmacia Fine Chemicals). The F(ab')2, Fab', or Fab fragments of these antibodies were prepared by digestion with pepsin or papain (15, 16 aaH or 1.0 mg/ml H. The quantity of bound ligand was determined after centrifugation of the cells in 100/~1 of suspension through 750/ll of oil at 8,000 g for 2 min (17).
Assay for Inhibition of H Binding to B Cells and EC3b by aaI-I. Purified H was labeled with 3H
by reductive methylation (18) and had a specific activity of 3.6 × 106 dpm//~g. The specific binding of [3H]H to Raji cells, BF cells, or EC3b was measured as previously described (3, 17) after treatment of the cells with either unlabeled H, aaH, or Fab anti-C3c.
Assay for B Cell Release of Factor I. (3) . For analysis of the B cell proteins reactive with aaH, the washed cells were solubilized with nonionic detergent (3). After removal of insoluble material by uhracentrifugation (3), the soluble B cell proteins from 5 × 10 v cells in 0.5 ml of buffer (3) were incubated with I0/zg of either purified aaH or nonimmune rabbit IgG for 16 h at 4°C. The rabbit IgG and any immune complexes were then collected by centrifugation after incubation for 4 h at 4°C with 10/zl of agarose-anti-rabbit IgG (Miles Laboratories, Inc., Research Products Div., Elkhart, IN). To remove nonspecifically bound cell proteins, the agarose-bound complexes were washed four times with ice-cold phosphate-buffered saline containing 1% Nonidet P40 (NP-40) (Particle Data Inc., Elmhurst, IL), 0.5% deoxycholate, 20% sucrose, 2 mM phenylmethylsulfonyl fluoride, 50 pg/ml soybean trypsin inhibitor, 25 mM benzamidine, 50 mM epsilon amino caproic acid (Sigma Chemical Co., St. Louis, MO), and 10 mM EDTA. The complexes were eluted from the agarose by incubation for 5 min at 100°C with 2% SDS, either with or without 0.1 M dithiothreitol, and electrophoresed in 7% polyacrylamide gel slabs (19). The gel tracks were then sliced into 2-mm segments that were solubilized by overnight incubation in 30% H202 at 56°C and counted in OCS scintillation fluid (Amersham Corp., Arlington Heights, IL). The molecular weight of radioactive protein bands was determined from their mobility relative to known molecular weight markers (Bio-Rad Laboratories, Richmond, CA) electrophoresed in parallel gel tracks.
For molecular weight analysis of the B cell proteins that had H-binding (H receptor) activity, the spent culture media from [SH]leucine intrinsically labeled Raft cells was cycled two times through a column containing 2 ml of either H-agarose (same as above) or control BSA-agarose (10 mg BSA per ml of agarose) (10) in 0.01 M phosphate-buffered saline, pH 7.5, with protease inhibitors (same as above). After a wash of the columns with 0.5 M NaCI in 0.1 M phosphate buffer, pH 7.5, the bound material was eluted with a mixture of 0.5% NP-40 and 0.5 M NaC1 in 0.1 M phosphate buffer, pH 7.5. The eluate was dialyzed against 62.5 mM Tris/HCl, pH 6.8, concentrated to 0.5 ml in the dialysis bag by dehydration with polyethylene glycol powder, treated with 2% SDS either with or without 0.1 M dithiothreitol for 5 min at 100°C, and electrophoresed in 7% polyacrylamide gel slabs that were analyzed for radioactivity and molecular weight as above.
Results

Characteristics of aaH.
After absorption with nonimmune goat IgG-agarose, the rabbit IgG fraction of aaH was labeled with t2sI and analyzed for binding to lymphocytes and EC3 (Table I) . Approximately 10-fold more [lZSI]aaH was bound to Raji and BF B-type lymphoblastoid cells and to EC3b than was bound to HSB Ttype lymphoblastoid cells, sheep E, or EC3d. By contrast, the labeled nonimmune rabbit IgG, obtained before immunization, was not bound selectively by any cell type. This absence of binding of nonimmune IgG indicated that Fc receptors were probably not a factor in the uptake of aaH by lymphoid cells. The specificity of the binding activity was further demonstrated by the finding that excess unlabeled aaH blocked (Table I) . To determine whether the aaH contained two distinct antibodies that were specific for either anti-H (anti-idiotype) or for C3b (anti-C3b), 200 mg of the aaH was absorbed in succession with nonimmune goat IgG-agarose and either goat-anti-Hagarose or C3-agarose. Samples of the absorbed aaH were then labeled with 125I and analyzed for cell-binding activity. Absorption with goat-anti-H-agarose removed all B cell-and EC3b-specific binding activity, and, likewise, absorption with C3-agarose removed all B cell-specific binding activity along with EC3b-binding activity. Only 1 mg of bound IgG was recovered after 4 M guanidine elution of either the anti-Hagarose or the C3-agarose. Finally, when the two different eluted IgG fractions were labeled with 125I, both bound to B cells and to EC3b in an apparently identical manner, and, in addition, the antibody eluted from C3-agarose bound to goat-anti-H-agarose (data not shown). It was concluded that probably a single anti-idiotype contained in the aaH reacted with both B cells and C3b.
To determine whether aaH blocked the binding of H to B cell H receptors, B cells were treated with either pure aaH or H and then tested for their ability to bind 3H-labeled H (Table II) . Both the aaH (100 #g/ml) and a 1,000-fold molar excess of unlabeled H blocked the uptake of [3H]H onto either Raji or BF cells. In addition, aaH also blocked the uptake of [3H]H onto EC3b. Because of this finding, a sheep IgG anti-C3b was compared with the aaH for its ability to block the uptake of [3H]H onto B cells. Treatment of B cells with l0 mg/ml of the sheep anti-C3b, which had an EC3b agglutinating titer of 1,600, had no effect on the uptake of [3H]H onto membrane H receptors (Table II) .
Factor H-like Activity ofaaH. Because the purified aaH resembled factor H in its binding specificity for C3b and B cell H receptors, aaH was examined for its ability to substitute for factor H in functions that are characteristic of factor H. Purified aaH was found to function with factor I as a cofactor for cleavage of fluid-phase C3b and as a potentiator for cleavage of bound C3b (Fig. 1 and Table III) . However, on a weight ratio comparison, C3-agarose affinity-purified aaH had only 0.1% of the activity of purified factor H. With both fluid-phase [3H]C3b (Fig. 1) and EC3b[3H] (data not shown), only small amounts of iC3b were detected by SDS-PAGE analysis after aaH and I treatment. When H was used rather than aaH, I treatment resulted in complete conversion of C3b to iC3b (Fig. 1) . The factor H-like activity of the aaH with I and bound C3b was more easily demonstrated by the Raji rosette test that is sensitive to very small amounts of bound iC3b (3) ( Table III) .
Because the binding of factor H to B cell H receptors had previously been shown to stimulate the release of B cell endogenous factor I (3), aaH was tested for its ability to trigger I release from Raji B cells (Table IV) . After treatment of B cells with either purified aaH or H, the cells were pelleted by centrifugation, and the harvested cell- Factor H 0 * Rosette assay performed in BDVEA buffer that inhibits H receptor-mediated Raji cell release of factor I (3). :[: Factor H concentration, 30 #g/ml. ~ urified anti-idiotype eluted from goat anti-H-agarose, 300/zg/ml. Nonimmune IgG, 300 p.g/ml; Fab anti-C3c, 1.0 mg/ml. free supernatant fluid was examined for I activity. The presence of small amounts of I was indicated by the anti-I-inhibitable conversion of Raji rosette-negative EC3b into Raji rosette-positive EC3bi (3). Factor I release was not detected with B cells treated with either nonimmune rabbit IgG or rabbit Fab anti-C3c. It was not possible to use the sheep IgG anti-C3b in this assay, as it agglutinated the EC3b indicator cells.
Molecular Weight Analysis of the B Cell Proteins That Bind to Either aaH or Factor H. After intrinsic [3H]
leucine labeling of Raji cell or BF cell proteins, each B cell type was solubilized with NP-40 and immunoprecipitated with purified aaH and anti-rabbit IgG-agarose beads. Analysis of the all-labeled immune precipitates by SDS-PAGE revealed two proteins of 100,000 Mr and 50,000 Mr without reduction and a single protein band of 50,000 Mr with complete reduction of disulfide bonds (Fig. 2) . A similar protein molecular weight profile was obtained with actH-immune precipitation of either Raji or BF B-cell lines, whereas no SDS-PAGE protein bands Fig. 3 , a similar protein molecular weight profile was obtained as with aaH immune precipitation (Fig. 2) . No comparable radioactive B cell proteins were detected when the control eluate of a BSA-agarose column was analyzed by the same procedure. When purified C3b was electrophoresed in parallel gel tracks, its known (20) 115,000 Mr a-chain and 75,000 Mr fl-chain structure was confirmed to be distinct from the B cell proteins that bound to aaH or H.
Discussion
aaH was shown to bind to both B lymphocyte membrane factor H receptors and C3b. The aaH blocked the uptake of H onto B cells and triggered B cells to release factor I in the same manner as did purified H. aaH also had H-like activity with C3b in that it served as a cofactor for I cleavage of fluid-phase C3b and potentiated I cleavage of bound C3b. SDS-PAGE analysis of B cell proteins, either immunoprecipitated with aaH or isolated by affinity chromatography on H-agarose, revealed a similar protein molecular weight profile that probably represents the membrane H receptor.
The binding of [125I]aaH to both B cells and EC3b was preliminary evidence for the H receptor specificity of aaH, as both B cells and C3b have H-binding sites. The finding that aaH blocked [3H]H binding to B cells and EC3b and, conversely, that H similarly blocked the binding of aaH, indicated that aaH bound at or near the Hbinding site of B ceils and C3b. Further evidence for the H-binding site specificity of aaH was the observation that aaH had the ability to substitute for H in reactions that are characteristic of H. Both purified H and aaH triggered B cells to release I. In addition, aaH not only bound to C3b, but it also functioned with I in the cleavage of C3b into iC3b. These same H-like activities could not be demonstrated with sheep IgG anti-C3b or rabbit Fab-anti-C3c. However, aaH had only 0.1% of the activity of H in I cleavage of C3b into iC3b. This finding suggests that H function with I may depend on H interaction with I as well as with C3b and that aaH may differ from H in that it binds only to C3b and does not also interact with I. Other studies (8) have previously suggested the existence of a trimolecular complex of C3b, H, and I that preceded iC3b formation. However, factor I also has been shown to bind to C3b-agarose (3) and EC3b (8) independently of H, suggesting that H binding to C3b may only serve to expose the I-cleavage site in C3b and that H itself may not bind to I. If this were the case, then perhaps aaH binds to the H-binding site of C3b and either does not expose the I-cleavage site or partially covers this site.
The finding that the aaH IgG fraction contained antibodies that were specific for C3b as well as for B cell H receptors was not unexpected. However, it was anticipated that the antibodies that were specific for the H-binding site of C3b would be distinct from those antibodies that were specific for the binding site of the H receptor. All B cell-binding activity of the aaH IgG fraction was absorbed and subsequently eluted from C3-agarose. This finding apparently indicates that C3b and H receptors have a similar H-binding site and, thus, probably bind to the same site in the H molecule. However, if this is the case, it is not clear how complexes bearing C3b,H could trigger H receptors (3), as it would be expected that the receptor-binding site in the H molecule would be occupied by C3b. This same paradox does not exist with Clq receptors. Clq receptors have been shown to be specific for the collagen portion of Clq, whereas immunoglobulin Fc binds to the globulin portion of Clq. This allows Clq-bearing IgG or IgM aggregates to bind to Clq receptors (21) . By comparison, for C3b,H complexes to trigger H receptors, the H molecule would either have to be bivalent in identical receptor-binding sites or be able to transfer from C3b to H receptors in an activated form. No evidence has ever been presented for an activated form of factor H. However, because purified H has been noted to have a tendency to aggregate with itself (3, and S. Ruddy, personnel communication), it is possible that H interaction with bound C3b might lead to similar H aggregation, so that C3b complexes might present H dimers or larger H aggregates to cells bearing H receptors. Alternatively, even though H has been thought to be monovalent in C3b binding sites (17, 22) , some of the data concerning the uptake of 125I-factor H by EAC 14°xy23b (22) vs. EC3b (17) could be interpreted as indicating that H was bivalent. Using EAC 14°xy23b that contained 64,000 bound C3b molecules per cell, Conrad et at. (22) measured an uptake of only 0.5 H molecules per C3b molecule and an H to C3b affinity constant of 109 L/M. By contrast, Kazatchkine et al. (17) , using EC3b containing 30,000 C3b per cell generated with an unstabilized convertase (C3b,Bb), observed an uptake of 1.0 H per C3b with an affinity constant of 1 × 10 -7 M (107 L/M). C3 fixation onto EAC14°xY2 is believed to generate large dense clusters of bound C3b molecules surrounding individual C4°xY2 sites, because the half-life of the C4°xY2 enzyme is 150 min at 32°C (23) . On the other hand, because the bound C3b,Bb enzyme has a half-life of only 4 min at 30°C (24) , it would be expected that only small numbers of C3b molecules would be fixed by individual unstabilized enzyme sites and that resulting C3b clusters would be small. If H were bivalent in C3b binding sites, then a single H molecule might be able to bridge two C3b molecules contained in a dense C3b cluster. This would result in an H binding of 0.5 molecules per C3b, and the cooperativity provided by dual-point attachment of H to two C3b molecules would greatly increase the H affinity constant over that observed with single-point H attachment to individual more widely spaced C3b molecules.
Because all of the various findings indicated that aaH was probably specific for H receptors, aaH immunoprecipitation was used in parallel with H-agarose affinity chromatography to characterize the molecular weight of B cell H receptors. Analysis by SDS-PAGE revealed two proteins of 100,000 and 50,000 Mr without reduction, and a single protein band at 50,000 Mr after complete reduction of disulfide bonds. From this data it appears possible that the membrane H receptor may consist of 50,000-Mr subunits, with the disulfide-linked subunits of the unreduced 100,000-Mr component possibly being distinct from the unreduced 50,000-Mr component. In future studies, larger quantities of H receptor will be isolated by H-agarose affinity chromatography and used for a more complete structural characterization of the receptor. Of particular interest will be determination of the carbohydrate composition of the receptor and the contribution of sugars to the binding site. A large portion of the structure of factor H is believed to be carbohydrate (1) .
The main use planned for the isolated H receptor is to produce a polyclonal anti-H receptor antibody that could be converted into F(ab')2 and Fab' fragments. The very small quantities of aaH available precluded their use in generation of such pepsinderived fragments. If both F(ab')2 and Fab' anti-H receptor bound to B cell H receptors, but only the F(ab')2 and not the Fab' antibody triggered I release, it would indicate that receptor cross-linkage by a bivalent H-ligand was probably required for triggering of receptor function. Such an F(ab')2 anti-H receptor, as well as purified H aggregates, would also be valuable specific probes of lymphocyte H receptor-mediated functions other than I release. It is noted with considerable interest that Hammann et al. (4) recently reported that purified human H triggers mouse spleen cell blastogenesis.
Summary
Antibody to the binding site (idiotype) of anti-factor H was shown to have specificity for both B lymphocyte membrane H receptors and C3b. Goat F(ab')2 antihuman H was purified by absorption and elution from H agarose and used for rabbit immunization to produce anti-anti-H (aaH). After absorption with nonimmune goat IgG, a2~I-labeled aaH bound to B lymphocytes and to sheep erythrocytes coated with C3b (EC3b) but did not bind to T lymphocytes or to EC3d. All B cell-and C3b-specific activities of the aaH were removed and subsequently recovered by absorption and elution of the antibody from either C3-agarose or goat-anti-H-agarose. This indicated that the aaH probably recognized a single common antigenic structure that was shared by anti-H, C3b, and the membranes of B cells. Affinity-purified aaH resembled H in that it bound to B cells, blocked the uptake of H onto B cell H receptors, and triggered B cells to release endogenous factor I (C3b inactivator). In addition, aaH functioned with factor I as either a cofactor for cleavage of fluid-phase C3b or a potentiator for cleavage of bound C3b. This same spectrum of C3 binding functions could not be demonstrated with either sheep anti-C3b or rabbit-anti-C3c. Analysis by sodium dodecyl sulfate-polyacrylamide get electrophoresis of the [3H]leucine intrinsically labeled B cell proteins reactive with the purified aaH revealed proteins of 100,000 Mr and 50,000 Mr without reduction, and after complete reduction of disulfide bonds, a single protein band of 50,000 Mr. This same protein molecular weight profile was also demonstrated with labeled B cell proteins that were absorbed and eluted from H-agarose. Thus, aaH is apparently specific for both B cell H receptors and C3b. However, because parallel analysis of C3b confirmed its known 115,000-and 75,000-Mr polypeptide chain structure, the H receptor is probably not C3b and shares only the structure of the H binding site with C3b.
